Thursday, February 2, 2017

BRIEF-Cytomx announces the first patient treated in phase 1/2 proclaim-072 trial

* Cytomx announces the first patient treated in phase 1/2

proclaim-072 trial

Source text for Eikon:

Further company coverage:

Read more

No comments:

Post a Comment